This medication is used to treat certain types of arthritis (rheumatoid arthritis, arthritis of the spine, psoriatic arthritis), certain bowel diseases (Crohn's disease, ulcerative colitis), and a certain severe skin disease (chronic plaque psoriasis). In these conditions, the body's defense system (immune system) attacks healthy tissues. Infliximab works by blocking the actions of a certain natural substance (tumor...
Read moreThe American College of Rheumatology Annual Scientific Meeting in Boston last week provided more good data on the new-and... Read more »
Rheumatoid arthritis is a chronic and progressive illness which has a large impact on those afflicted. The destruction of joints can... Read more »
Over the past few years, studies have shown that people with rheumatoid arthritis and other rheumatic diseases have a higher risk of... Read more »
I am often asked what treatment or combination of treatments should be used in rheumatoid arthritis. The honest answer is that there is,... Read more »
Centocor, Inc. announced on August 14 that the FDA has expanded marketing approval for REMICADE® (infliximab) for the treatment of... Read more »
This is a study to assess Remicade's effectiveness in rheumatoid arthritis (RA) patients who have not responded well to treatment with a combination... Read more »
This is a study to assess the effectiveness of Remicade in rheumatoid arthritis (RA) patients who have not responded adequately to treatment with... Read more »
This is a study to determine the effectiveness of Remicade in patients with active rheumatoid arthritis who are not responding well to at least three... Read more »
The U.S. Food and Drug Administration (FDA) has begun a safety review of tumor necrosis factor (TNF) blockers, a class of drugs that includes the... Read more »
Scientists at the University of Amsterdam in the Netherlands have found that adult rheumatoid arthritis (RA) patients are less likely to respond to... Read more »